Jun 13, 2021 · View information for healthcare providers about OPZELURA® dosing for patients with mild to moderate atopic dermatitis. See the Full Prescribing Information, including Boxed Warning, …

OPZELURA is indicated for the topical treatment of nonsegmental vitiligo in adult and pediatric patients 12 years of age and older. Limitations of Use: Use of OPZELURA in combination with therapeutic …

Jun 13, 2021 · Learn about treatment with OPZELURA®, including mechanism of action, clinical trials and results, dosing, and helpful resources. See the Full Prescribing Information, including Boxed …

See info for healthcare professionals about OPZELURA® across all uses. Learn about the patient support program. See Full Prescribing Information, including Boxed Warning, and Medication Guide …

View information on the mechanism of action of OPZELURA® for people with mild to moderate atopic dermatitis. See the Full Prescribing Information, including Boxed Warning, and Medication Guide.

View info about OPZELURA® dosing for patients with nonsegmental vitiligo. See the Full Prescribing Information, including Boxed Warning, and Medication Guide.

OPZELURA is indicated for the topical and chronic treatment of mild to moderate atopic dermatitis in adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with …

View info for healthcare providers about the OPZELURA® mechanism of action. See the Full Prescribing Information, including Boxed Warning, and Medication Guide.

See before and after photos of patients using OPZELURA® for atopic dermatitis treatment. See the Full Prescribing Information, including Boxed Warning, and Medication Guide.

See OPZELURA® facial repigmentation results in people with nonsegmental vitiligo. See the Full Prescribing Information, including Boxed Warning, and Medication Guide.